Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medically-supervised Withdrawal vs. Agonist Maintenance in the Treatment of Pregnant Women With Opioid Use Disorder: Maternal, Fetal, and Neonatal Outcomes

NCT04049799 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.

NCT NCT04049799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medically-supervised Withdrawal vs. Agonist Maintenance in the Treatment of Pregnant Women With Opioid Use Disorder: Maternal, Fetal, and Neonatal Outcomes
Lead sponsor
University of Vermont
Phase
Observational
Overall status
Completed
Start date
August 8, 2019
Completion date
February 1, 2024
Enrollment
88 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal abstinence syndrome, neonatal opioid withdrawal syndrome, opioid withdrawal, opioid-use disorder